Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 5, 2026 20:16 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantSeries I Warrants · Derivative | 1,599,999 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025928 · rdgdoc.xml · derivative · entry 2 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,926,335 Underlying: Common Stock · 1,599,999 shares Expires 2031-08-03 F1 · derivative.exercise_price: On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. F1 · price: On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. F1 · balance_after: On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:16 UTC |
KLEMP WALTER VDirector · CEO and President
|
PurchaseCommon Stock | 533,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025928 · rdgdoc.xml · nonDerivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 564,340 F1 · price: On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:16 UTC |
Foster Jonathan P.Chief Financial Officer
|
PurchaseSeries I Warrants · Derivative | 879,999 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025929 · rdgdoc.xml · derivative · entry 2 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,027,717 Underlying: Common Stock · 879,999 shares Expires 2031-08-03 F1 · derivative.exercise_price: On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. F1 · price: On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:16 UTC |
Foster Jonathan P.Chief Financial Officer
|
PurchaseCommon Stock | 293,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025929 · rdgdoc.xml · nonDerivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,673 F1 · price: On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:15 UTC |
PICKER DONALD HChief Science Officer
|
PurchaseSeries I Warrants · Derivative | 519,999 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025927 · rdgdoc.xml · derivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,595 Underlying: Common Stock · 519,999 shares Expires 2026-08-03 F1 · derivative.exercise_price: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. F1 · price: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. F1 · balance_after: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:15 UTC |
PICKER DONALD HChief Science Officer
|
PurchaseCommon Stock | 173,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025927 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,086 F1 · price: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:00 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021611 · rdgdoc.xml · derivative · entry 6 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,336 Underlying: Common Stock · 360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 22, 2023, the reporting person was granted 1,439 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On June 22, 2023, the reporting person was granted 1,439 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · balance_after: Includes 250,002 shares of common stock underlying Series E warrants to purchase common stock. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:00 UTC |
KLEMP WALTER VDirector · CEO and President
|
Tax withholdingCommon Stock | 88 | $3.12 | $274.56 |
DisclosureSEC source: 0001437749-26-021611 · rdgdoc.xml · nonDerivative · entry 4 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,007 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:00 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionCommon Stock | 360 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021611 · rdgdoc.xml · nonDerivative · entry 3 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:01 UTC |
PICKER DONALD HChief Science Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · derivative · entry 6 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,596 Underlying: Common Stock · 50 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 22, 2023, the reporting person was granted 283 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On June 22, 2023, the reporting person was granted 283 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:01 UTC |
PICKER DONALD HChief Science Officer
|
Tax withholdingCommon Stock | 21 | $3.12 | $65.52 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 4 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:01 UTC |
PICKER DONALD HChief Science Officer
|
Exercise / conversionCommon Stock | 71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:00 UTC |
Foster Jonathan P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 174 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021610 · rdgdoc.xml · derivative · entry 6 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,718 Underlying: Common Stock · 174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 22, 2023, the reporting person was granted 693 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On June 22, 2023, the reporting person was granted 693 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · balance_after: Includes 100,003 shares of common stock underlying Series E warrants to purchase common stock. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:00 UTC |
Foster Jonathan P.Chief Financial Officer
|
Tax withholdingCommon Stock | 41 | $3.12 | $127.92 |
DisclosureSEC source: 0001437749-26-021610 · rdgdoc.xml · nonDerivative · entry 4 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,340 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:00 UTC |
Foster Jonathan P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021610 · rdgdoc.xml · nonDerivative · entry 3 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:00 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021611 · rdgdoc.xml · derivative · entry 5 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,696 Underlying: Common Stock · 150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2022, the reporting person was granted 600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 20, 2022, the reporting person was granted 600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · balance_after: Includes 250,002 shares of common stock underlying Series E warrants to purchase common stock. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:00 UTC |
KLEMP WALTER VDirector · CEO and President
|
Tax withholdingCommon Stock | 37 | $2.88 | $106.56 |
DisclosureSEC source: 0001437749-26-021611 · rdgdoc.xml · nonDerivative · entry 2 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,728 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:00 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionCommon Stock | 150 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021611 · rdgdoc.xml · nonDerivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:01 UTC |
PICKER DONALD HChief Science Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · derivative · entry 5 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,667 Underlying: Common Stock · 44 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2022, the reporting person was granted 173 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 20, 2022, the reporting person was granted 173 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:01 UTC |
PICKER DONALD HChief Science Officer
|
Tax withholdingCommon Stock | 13 | $2.88 | $37.44 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 703 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:01 UTC |
PICKER DONALD HChief Science Officer
|
Exercise / conversionCommon Stock | 44 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:00 UTC |
Foster Jonathan P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021610 · rdgdoc.xml · derivative · entry 5 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,892 Underlying: Common Stock · 109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2022, the reporting person was granted 434 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 20, 2022, the reporting person was granted 434 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · balance_after: Includes 100,003 shares of common stock underlying Series E warrants to purchase common stock. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:00 UTC |
Foster Jonathan P.Chief Financial Officer
|
Tax withholdingCommon Stock | 31 | $2.88 | $89.28 |
DisclosureSEC source: 0001437749-26-021610 · rdgdoc.xml · nonDerivative · entry 2 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,207 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:00 UTC |
Foster Jonathan P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021610 · rdgdoc.xml · nonDerivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:07 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantPerformance Based Restricted Stock Units · Derivative | 750,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-035182 · rdgdoc.xml · derivative · entry 2 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,960,731 Underlying: Common Stock · 750,000 shares Expires 2035-11-12 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:07 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantStock option (right to buy) · Derivative | 830,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035182 · rdgdoc.xml · derivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,210,731 Underlying: Common Stock · 830,000 shares Expires 2035-11-12 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 16:07 UTC |
Yan JoyDirector
|
GrantStock Options (right to buy) · Derivative | 150,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035179 · rdgdoc.xml · derivative · entry 1 Yan Joy · CIK 0001866109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,001 Underlying: Common Stock · 150,000 shares Expires 2035-11-12 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 16:05 UTC |
George Robert E.Director
|
GrantStock Options (right to buy) · Derivative | 150,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035168 · rdgdoc.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,336 Underlying: Common Stock · 150,000 shares Expires 2035-11-12 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:08 UTC | GrantPerformance Based Restricted Stock Units · Derivative | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-035186 · rdgdoc.xml · derivative · entry 2 PICKER DONALD H · CIK 0001266800 · CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,508 Underlying: Common Stock · 200,000 shares Expires 2035-11-12 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest. Read SEC document |
|
| November 12, 2025 Filed Nov 14, 2025 21:08 UTC | GrantStock option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035186 · rdgdoc.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,508 Underlying: Common Stock · 200,000 shares Expires 2035-11-12 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
|
| November 12, 2025 Filed Nov 14, 2025 21:08 UTC |
Foster Jonathan P.EVP & CFO
|
GrantPerformance Based Restricted Stock Units · Derivative | 400,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-035184 · rdgdoc.xml · derivative · entry 2 Foster Jonathan P. · CIK 0001545414 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,017,695 Underlying: Common Stock · 400,000 shares Expires 2035-11-12 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:08 UTC |
Foster Jonathan P.EVP & CFO
|
GrantStock option (right to buy) · Derivative | 600,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035184 · rdgdoc.xml · derivative · entry 1 Foster Jonathan P. · CIK 0001545414 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,617,695 Underlying: Common Stock · 600,000 shares Expires 2035-11-12 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:06 UTC |
Cermak ElizabethDirector
|
GrantStock Options (right to buy) · Derivative | 150,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035177 · rdgdoc.xml · derivative · entry 1 Cermak Elizabeth · CIK 0001471971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,668 Underlying: Common Stock · 150,000 shares Expires 2035-11-12 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:06 UTC |
CANNON MICHAEL DDirector
|
GrantStock Options (right to buy) · Derivative | 150,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035174 · rdgdoc.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,336 Underlying: Common Stock · 150,000 shares Expires 2035-11-12 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:05 UTC |
Climaco John MDirector
|
GrantStock Options (right to buy) · Derivative | 150,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035170 · rdgdoc.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,169 Underlying: Common Stock · 150,000 shares Expires 2035-11-12 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:24 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 28,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033683 · rdgdoc.xml · derivative · entry 3 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,380,731 Underlying: Common Stock · 28,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:24 UTC |
KLEMP WALTER VDirector · CEO and President
|
Tax withholdingCommon Stock | 7,001 | $0.50 | $3,479.50 |
DisclosureSEC source: 0001437749-25-033683 · rdgdoc.xml · nonDerivative · entry 2 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 765,356 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:24 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionCommon Stock | 28,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-033683 · rdgdoc.xml · nonDerivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 772,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:25 UTC |
PICKER DONALD HChief Science Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033684 · rdgdoc.xml · derivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,508 Underlying: Common Stock · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date F3 · derivative.expiration_date: On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:25 UTC |
PICKER DONALD HChief Science Officer
|
Tax withholdingCommon Stock | 2,131 | $0.50 | $1,059.11 |
DisclosureSEC source: 0001437749-25-033684 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,771 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:25 UTC |
PICKER DONALD HChief Science Officer
|
Exercise / conversionCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-033684 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:24 UTC |
Foster Jonathan P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 20,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033682 · rdgdoc.xml · derivative · entry 3 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,017,695 Underlying: Common Stock · 20,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:24 UTC |
Foster Jonathan P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 5,023 | $0.50 | $2,496.43 |
DisclosureSEC source: 0001437749-25-033682 · rdgdoc.xml · nonDerivative · entry 2 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:24 UTC |
Foster Jonathan P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 20,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-033682 · rdgdoc.xml · nonDerivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 23, 2025 Filed Jun 23, 2025 20:35 UTC |
KLEMP WALTER VDirector · CEO and President
|
PurchaseSeries E Warrants · Derivative | 2,027,025 | Not disclosed Strike: $0.37 | Not disclosed |
DisclosureSEC source: 0001437749-25-021050 · rdgdoc.xml · derivative · entry 8 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,409,481 Underlying: Common Stock · 2,027,025 shares Expires not disclosed F5 · price: On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. F5 · derivative.exercise_date: On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. F5 · derivative.expiration_date: On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. Read SEC document |
| June 23, 2025 Filed Jun 23, 2025 20:35 UTC |
KLEMP WALTER VDirector · CEO and President
|
PurchaseCommon Stock | 675,675 | $0.37 | $249,999.75 |
DisclosureSEC source: 0001437749-25-021050 · rdgdoc.xml · nonDerivative · entry 5 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743,607 F5 · price: On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. Read SEC document |
| June 23, 2025 Filed Jun 23, 2025 20:35 UTC |
Foster Jonathan P.Chief Financial Officer
|
PurchaseSeries E Warrants · Derivative | 810,810 | Not disclosed Strike: $0.37 | Not disclosed |
DisclosureSEC source: 0001437749-25-021051 · rdgdoc.xml · derivative · entry 8 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,038,320 Underlying: Common Stock · 810,810 shares Expires not disclosed F5 · price: On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. F5 · derivative.exercise_date: On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. F5 · derivative.expiration_date: On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. Read SEC document |
| June 23, 2025 Filed Jun 23, 2025 20:35 UTC |
Foster Jonathan P.Chief Financial Officer
|
PurchaseCommon Stock | 270,270 | $0.37 | $99,999.90 |
DisclosureSEC source: 0001437749-25-021051 · rdgdoc.xml · nonDerivative · entry 5 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,587 F5 · price: On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval. Read SEC document |
| June 22, 2025 Filed Jun 23, 2025 20:35 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 8,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-021050 · rdgdoc.xml · derivative · entry 7 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,456 Underlying: Common Stock · 8,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 22, 2025 Filed Jun 23, 2025 20:35 UTC |
KLEMP WALTER VDirector · CEO and President
|
Tax withholdingCommon Stock | 2,190 | $0.27 | $584.73 |
DisclosureSEC source: 0001437749-25-021050 · rdgdoc.xml · nonDerivative · entry 4 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,932 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.